Information
Code | FAR696 |
Name | |
Term | 2024-2025 Academic Year |
Term | Fall and Spring |
Duration (T+A) | 3-0 (T-A) (17 Week) |
ECTS | 5 ECTS |
National Credit | 3 National Credit |
Teaching Language | Türkçe |
Level | Doktora Dersi |
Type | Normal |
Mode of study | Yüz Yüze Öğretim |
Catalog Information Coordinator | Prof. Dr. NURAN ÖĞÜLENER |
Course Instructor |
Prof. Dr. NURAN ÖĞÜLENER
(A Group)
(Ins. in Charge)
|
Course Goal / Objective
Proposed to provide to explain the effects, mechanisms of action, side effects, contraindications, interactions and clinical pharmacology of drugs used in the treatment of cardiovascular diseases.
Course Content
Fundamentals of physiopathology of cardiovascular diseases, physiological and pharmacological properties of drugs affecting this system, mechanisms of action, side effects, contraindications and drug interactions
Course Precondition
None
Resources
Basic & Clinical Pharmacology, McGraw-Hill Medical Books, 2018 Goodman and Gilman's The Pharmacologi-cal Basis of Therapeutics-13 th Edition, McGraw-Hill Medical Books, 2018 Lippincott's Illustrated Reviews: Pharmacology,Lippincott Williams & Wilkins, 2018
Notes
https://go.drugbank.com/
Course Learning Outcomes
Order | Course Learning Outcomes |
---|---|
LO01 | Defines the physiopathology of cardiovascular diseases. |
LO02 | Classifies drugs effective on cardiovascular system. |
LO03 | Classify the antihypertensive drugs. |
LO04 | Explain the antihypertensive effect mechanism of antihypertensive drugs, their use, side effects, contrandications and interactions. |
LO05 | Classifiy the drugs used in peripheral vascular diseases and explain and compare the pharmacokinetics, pharmacodynamics and mechanism of action, side effects, contraindications and interactions of the drugs used. |
LO06 | Classify antianginal drugs, explain the mechanism of action, pharmacological effects, side effects, contraindications and interactions of antianginal drugs. |
LO07 | Compare the effects, mechanisms of action, pharmacokinetics, side effects, contraindications and interactions of antiarrhythmic drugs. |
LO08 | Explain the effects, mechanisms of action, side effects, contraindications, interactions and clinical pharmacology of drugs used in heart failure. |
LO09 | Explain the mechanism of action, pharmacokinetic properties, side effects, contraindications and interactions of hypolipidemic drugs. |
LO10 | Antithrombotic drugs: classify anticoagulant drugs, antiplatelet drugs and thrombolytic drugs and explain and compare their pharmacokinetics, pharmacodynamics and mechanisms of action. |
Relation with Program Learning Outcome
Order | Type | Program Learning Outcomes | Level |
---|---|---|---|
PLO01 | Beceriler - Bilişsel, Uygulamalı | Discusses the mechanisms of action, side effects, and toxic effects of drugs. | 5 |
PLO02 | Beceriler - Bilişsel, Uygulamalı | Explains drug effects, drug interactions and effects on organ systems with a systematic approach | 4 |
PLO03 | Yetkinlikler - Alana Özgü Yetkinlik | Plans, implements and finalizes a scientific project | |
PLO04 | Bilgi - Kuramsal, Olgusal | Recognize the research areas and research techniques of pharmacology | |
PLO05 | Yetkinlikler - Alana Özgü Yetkinlik | Comparatively examines and compiles scientific articles in the field of pharmacology. | 3 |
PLO06 | Yetkinlikler - Bağımsız Çalışabilme ve Sorumluluk Alabilme Yetkinliği | Prepares the experimental setup for an in vitro or in vivo pharmacological study and solves problems. | |
PLO07 | Yetkinlikler - Alana Özgü Yetkinlik | He/she transforms the data obtained from the research project into a scientific research article. | |
PLO08 | Yetkinlikler - Alana Özgü Yetkinlik | Evaluates drug use and its effects in society due to his/her knowledge about drugs. | 3 |
PLO09 | Bilgi - Kuramsal, Olgusal | Explain clinical phase studies in drug development. | |
PLO10 | Beceriler - Bilişsel, Uygulamalı | Evaluates and interprets study data statistically. | |
PLO11 | Beceriler - Bilişsel, Uygulamalı | contributes to public health with its awareness of rational drug use. | 3 |
Week Plan
Week | Topic | Preparation | Methods |
---|---|---|---|
1 | Introduction to Cardiovascular System Drugs | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Beyin Fırtınası |
2 | Hypertension and Antihypertensive Drugs | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Beyin Fırtınası |
3 | Diuretics, Mechanisms of Action and Pharmacological Effects | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Beyin Fırtınası |
4 | Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Renin Inhibitors | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Beyin Fırtınası |
5 | Classification of Calcium Channel Blockers, Effects, Mechanisms of Action, Side Effects, Contraindications, Interactions and Therapeutic Uses | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Tartışma, Beyin Fırtınası |
6 | Beta Adrenergic Receptor Blockers | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Beyin Fırtınası |
7 | Drugs Used in Peripheral Vascular Diseases | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Soru-Cevap |
8 | Mid-Term Exam | Should study presentations and textbooks | Ölçme Yöntemleri: Yazılı Sınav |
9 | Angina Pectoris and Drugs Used as Antianginal | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Beyin Fırtınası |
10 | Antiarrhythmic Drugs | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Soru-Cevap, Anlatım |
11 | Drugs Used Against Congestive Heart Failure | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Beyin Fırtınası, Anlatım |
12 | Hypolipidemic Drugs | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Beyin Fırtınası |
13 | Antithrombotic Drugs | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Soru-Cevap, Anlatım |
14 | Hemostatic Drugs, Blood Products, Plasma Volume Expanding Solutions, Blood And Plasma Products | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Soru-Cevap |
15 | Other Drugs Used in Water and Electrolyte Balance Disorders; Drugs Used in Acid-Base Balance Disorders | The subject should be reviewed from the textbooks | Öğretim Yöntemleri: Anlatım, Soru-Cevap |
16 | Term Exams | Should be study to textbooks and presentations | Ölçme Yöntemleri: Yazılı Sınav |
17 | Term Exams | Should be study to textbooks and presentations | Ölçme Yöntemleri: Yazılı Sınav |
Student Workload - ECTS
Works | Number | Time (Hour) | Workload (Hour) |
---|---|---|---|
Course Related Works | |||
Class Time (Exam weeks are excluded) | 14 | 2 | 28 |
Out of Class Study (Preliminary Work, Practice) | 14 | 4 | 56 |
Assesment Related Works | |||
Homeworks, Projects, Others | 0 | 0 | 0 |
Mid-term Exams (Written, Oral, etc.) | 1 | 9 | 9 |
Final Exam | 1 | 20 | 20 |
Total Workload (Hour) | 113 | ||
Total Workload / 25 (h) | 4,52 | ||
ECTS | 5 ECTS |